Atlas Trials

Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

Clinical trial NCT05961761 · RECRUITING

Trial details

NCT number
NCT05961761
Sponsor
Niels Junker
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Soft Tissue Sarcoma AdultAngiosarcomaUndifferentiated Pleomorphic Sarcoma
Start date
2021-08-17
Primary completion
2028-01-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.